TELA Bio (NasdaqGM:TELA) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Company ParticipantsCaitlin Roberts - Director of MedTech Equity ResearchJeff Blizard - PresidentJim Hagen - SVP of CommercialLouisa Smith - Investor RelationsRoberto Cuca - COO and CFOTony Koblish - Co Founder and CEOConference Call ParticipantsFrank Takkinen - Senior Research AnalystMatthew O'Brien - Senior Research AnalystMichael Sarcone - Equity Research AnalystOperatorGood afternoon, ladies and gentlemen, and welcome to the TELA ...

TELA Bio (NasdaqGM:TELA) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Company ParticipantsCaitlin Roberts - Director of MedTech Equity ResearchJeff Blizard - PresidentJim Hagen - SVP of CommercialLouisa Smith - Investor RelationsRoberto Cuca - COO and CFOTony Koblish - Co Founder and CEOConference Call ParticipantsFrank Takkinen - Senior Research AnalystMatthew O'Brien - Senior Research AnalystMichael Sarcone - Equity Research AnalystOperatorGood afternoon, ladies and gentlemen, and welcome to the TELA ...

TELA Bio (NasdaqGM:TELA) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Speaker8Good afternoon, ladies and gentlemen, and welcome to the TELA Bio fourth quarter and full year 2025 earnings conference call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the prepared remarks. As a reminder, this conference call is being recorded. I would now like to turn the conference call over to Louisa Smith from Investor Relations.Speaker5Thank you, Jonathan, and good a ...